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Objective. For successful sustainable weight reduction, a multimodal program including behaviour therapy is needed. Lifestyle
modiﬁcationismostlyusedforobesityBMI<40kg/m2.Thepresentstudydemonstratedtheeﬀectofanin-patientnondietlifestyle
program for patients with BMI >40kg/m2 with psychological comorbidity. Research Methods and Procedere.Ar e t r o s p e c t i v ed a t a
analysis of 99participants who passedthe programbased onmoderate activity, healthy andregular food intake over metabolic rate
and behaviour therapy was conducted. Results.6 4h a daB M I>40kg/m2 (mean value 49.99 ± 8.74). The relative weight reduction
was −6.9 ± 3.9%; (Friedman test P<0.05). Binary logistic regression analysis for n = 79 revealed that the achievement of the
weight reduction goal (0.5kgper week; predictors: sex, incidence of MTS, duration of in-patient therapy, psychological symptoms,
BMI and activity level at baseline) was associated with a shorter duration of in-patient therapy (P = 0.007) and higher BMI at
baseline (P = 0.010). Conclusion. Participants with BMI >40kg/m2 may achieve signiﬁcant changes of weight reduction and
psychological symptoms. However, the primary outcome should not be weight reduction. It is necessary to identify the beneﬁts of
lifestyle modiﬁcation on changing risk proﬁles and emotional regulation of food intake.
1.Introduction
Worldwide, already1billionpeople areoverweight andmore
than 300 million are obese [1, 2]. Particularly, the increase
in extremely overweight people was recently demonstrated
(BMI ≥ 40kg/m2)[ 1]. In the USA, already the prevalence of
4.8% in this group has been recorded [2].
Obesity is the result of a long-term positive energy bal-
ance, caused by lack of exercise combined with hypercaloric
nutrition [3, 4]. An eﬀective therapy for this multifactor
health problem is the combination of multiple therapy facil-
ities [5]. Also for a successful long-term eﬀect, a multimodal
treatment [5–7] aimed at the motivation of the obese patient
for lifestyle modiﬁcation is essential. Increasing physical
activity and diet are important for an eﬀective weight
management [8].
However,avariedmixingfoodwiththereferencevalueof
thebasalmetabolismistobepreferredfortheeﬀectivenessof
changing the food pattern because there is often a resulting
nutrient deﬁciency and the risk of drop-outs [7].
The role of activity producing a long-term eﬀect in
weight loss is well documented [9, 10]. But, there exists no
consistent recommendation how much activity is enough to
have the best eﬀect. But, a higher duration of activity, such2 Journal of Obesity
as more than 200min/week (P<0.001), is more eﬀective to
produce greater weight loss [11]. This ﬁnding implicates a
higher duration of activity than recommended [5, 12, 13].
Energyexpenditureproducedbyphysicalactivityandthe
food intake must result in a daily energy deﬁcit of minimum
500kcal [9].
Lifestyle modiﬁcation in the context of more activity is
the key point for successful weight management, as reported
in earlier studies [11–14]. However, the description of the
amountofactivityvariesandtherearenoreportedproﬁtsfor
thepatientswithregardstoqualityoflife.Thereisalsolackof
standardized deﬁnition about lifestyle intervention [15–19].
Whereas the usual kinds of lifestyle modiﬁcation are mostly
used for obesity close to BMI 40kg/m2 [20], patients with a
BMIover50kg/m2 shouldalsostartwithacombinedtherapy
in an in-patient setting [7, 21].
Obesity is linked to major depression disorders. Pagoto
et al. [22] reported on 131 subjects with an average BMI
of 43.1 that 17% were depressive, diagnosed via clinical
interview (addressing DSM-IV criteria). The often discussed
comorbidityofdepressionasabarriertochangeofbehaviour
is approached by Schneider et al. [23]. So, the success
is currently optimized with related behavioural-therapeutic
elements [5] for motivation and stabilisation [24].
We hypothesized that an in-patient multidisciplinary
nondiet weight reduction program has eﬀectiveness for pa-
tients with a BMI >40kg/m2 and psychological comor-
bidities. In detail, we assumed that patients with a BMI
>40kg/m2 can lose 5% of their initial weight with an in-
patientmultidisciplinarynondietweightreductionprogram.
2. Method
2.1. Participants. 198 patients with a BMI >30kg/m2 and
psychological comorbidities ﬁnished a multidisciplinary in-
patientnondietweightreductionprogrambetweenFebruary
2007 and August 2010. In consideration of the exclusion and
inclusion criteria (Table 1), 99 patients could be considered
in a pre/postanalysis. To evaluate the eﬀect of the program,
a followup after 3, 6, and 9 month posttreatment was con-
ducted. The in-patient treatment took 8 to 12 weeks with a
structured week timetable.
2.2. Treatment. All group interventions were not construc-
tive on each other because of the open-group situation.
Activities like aqua gymnastic, walking, or a condition and
coordination training (aerobic low impact and elements of
resistance training using the own bodyweight), elements
of relaxation, and body awareness as well as behavioural-
therapeutic elements of motivation, stabilisation, and emo-
tional regulation in group and individual settings for opti-
mizing the success [5] were included. The activities were
composed that the patients could integrate them in the daily
routine. The behavioural therapy is taking place in group
interventions and two individual calls. For the regulation
of emotions, the research group have integrated a Skills-
training once a week.
This extensive program is developed since January 2007
and the interventions are shown in Table 2.
Objective and subjective parameters were measured pre-
and posttreatment. In Table 3, the parameters and their
instruments of assessment are shown.
2.3. Measures. To evaluate the HRQL, the generic in-
strument—Short Form-36 (SF-36), a valid self-adminis-
tered questionnaire [25]—was used. For the impact of
psychological symptoms, also a self-reported questionnaire,
the SCL-90 R (symptom Check list), was used [26]. Eating
habitswereassessedwitha3factor-eatingquestionnaireFEV
[27]. Body composition was measured with a bioimpedance
analysis instrument (DATA INPUT Nutriguard-M). Food
intake and activity were assessed with questionnaires of the
validated “Schlank ohne Di¨ at” (SOD, lean without diet) pro-
gram [28]. For height, weight, and the waist circumference,
standardized instruments were applied.
2.4. Statistical Analysis. For analysis, PASW statistics 18
was used. The objective parameter and dependent variable
weight reduction was standardized with respect to an
intended 5% weight reduction goal. Due to the non-
Gaussian distribution of the data, tested with the
Kolmogorow-Smirnow test, nonparametric tests (Wilcoxon
test, Friedman test) were used for pre/postanalyses. The
statistical signiﬁcance was set at P<0.05 (two tailed).
For parameter estimates, 95% conﬁdence intervals were
also computed. Binary logistic regression was used to
identify predictors of achieving the weight reduction goal.
Independent variables were based on previous ﬁndings:
duration of the in-patient therapy [29], sex, age, BMI [30],
the psychological symptoms (GSI) [23], and the baseline
ﬁtlevel [11, 13].
In consideration of the aim of this study, the sample was
also split into participants with BMI <40kg/m2 and BMI
>40kg/m2.
3. Results
3.1. Sample. Data from 99 participants were obtained from
medical records retrospectively.
68 (68.7%) women and 31 (31.3%) men with the mean
age of 43.79 ± 12.44 (♀ 44.12 ± 12.56; ♂ 43.06 ± 12.36) were
analysed. The BMI at baseline was 44.96 ± 9.93 (♀ 44.31 ±
9.61; ♂ 46.38 ± 10.61). The duration of therapy was 71.39 ±
16.2 days.
In consideration of the aim of the study to identify the
eﬀectiveness of a nondiet multidisciplinary weight reduction
program,wefocusedonthesubgroupwithaBMI>40kg/m2.
Sixty-four participants had a BMI >40kg/m2 (mean value
49.99 ± 8.74) and were included for further analysis. The
mean age was 43.76 ± 12.45 years. 43 (67.2%) participants
werewomen.Thedurationofin-patienttherapywas75.33 ±
14.897.Thirtyofthe64participants(46.9%)hadametabolic
syndrome.
The mean load of psychological symptoms at baseline
was 0.95 ± 0.65 and the subjective ﬁtlevel was 21.83 ± 15.57.
Objective parameters like body fat were at baseline 47.01 ±
7.01% and the waist circumference 147.18 ± 20.36cm
(Table 4).Journal of Obesity 3
Table 1: Inclusion and exclusion criteria of the study.
Exclusion Inclusion
(i) Bulimia nervosa (i) Adults with a BMI ≥ 30kg/m2 and psychological
comorbidities classiﬁed to ICD-10 criteria
(ii) Serious personality disorder (ii) Suﬃcient mobility for participation on activities and
(iii) Schizophrenia (iii) Cooperativeness for all parts of the program
(iv) Conduct disorders
(v) Serious reduction of intelligence
(vi) Patients after a myocardial infarct (MCI) and heart insuﬃciency
(NYHA III/IV)
(vii) The existence of diabetes mellitus type I
(viii) Renal insuﬃciency
(ix) Serious COPD or asthma bronchial
(x) Serious hormonal disorders
(xi) Tumours
(xii) Lactation or pregnancy
(xiii) Attendance on another study or weight loss program at the same time
(xiiii) Patients with a regularly higher dosed medication known to aﬀect
appetite and/or weight like corticosteroid, SHD-hormones, or diuretics
which are taken in the last 3 months
Table 2: Weekly timetable of interventions of the “schwerelos” program.
Medical science:
(i) somatic comorbidities and complications
(ii) medication
Medical visits 2x ´ a9 0m i n
Surgery hour 1x ´ a6 0m i n
Psychiatric consultation 1x ´ a6 0m i n
Psychology:
(i) behaviour
(ii) emotion
(iii) cognition
(iv) motivation
Individual therapy 2x ´ a5 0m i n
Group intervention 2x ´ a6 0m i n
Skills and social competence training each 2x ´ a60min
Self-image 1x ´ a6 0m i n
Relaxation 1x ´ a6 0m i n
Nutrition:
(i) balanced meal (food guide pyramid) Nutrition information 2x ´ a6 0m i n
(ii) food pattern, typus of food intake Individual counseling 1x ´ a6 0m i n
Activity:
(i) cardiotraining
(ii) strengthendurance
Aqua-gymnastic 2x ´ a3 0m i n
Music-gymnastic/low-impact 2x ´ a3 0m i n
Walking 2x ´ a3 0m i n
With the exception of triglycerides, LDL-cholesterol, and
alexithymia from TAS 26, diﬀerences of all other measured
parameters (t1v e r s u st2) were signiﬁcant (P<0.05)
(Table 5).
T h er e l a t i v ew e i g h tr e d u c t i o no ft h eB M I>40kg/m2
subgroup was ∅−6.9 ± 3.9%. The standardized weight
(5% weight reduction goal) for both subgroups is shown
in Figure 1. Weight reduction over time was signiﬁcant for
both groups (P<0.001) with a signiﬁcant group diﬀerence
(z =− 2.606; P = 0.009) at posttreatment. On average,
both groups achieved the 5% weight goal after intervention,
patients with a BMI >40kg/m2 already at week eight. 42 of
64 (65.6%) patients with BMI >40kg/m2 achieved the 5%
weight reduction goal.
Therelativeweightreductionandchangesinthesomato-
form dimension of the SCL-90R, the dimension body pain
of the SF-36, % body fat, and waist circumference were
signiﬁcant (Spearman correlation P<0.05; Table 6).
We conducted a binary logistic regression analysis
including also the patients with BMI <40kg/m2 (total n =
79) regarding the achievement of the weekly weight reduc-
tion goal of a loss of 0.5kg in average per week [28]t o
test whether patients with BMI >40kg/m2 and patients with
BMI <40kg/m2 diﬀered signiﬁcantly in treatment outcomes.
Predictors were participant, sex, incidence of the metabolic
syndrome, duration of the in-patient therapy, BMI, waist
circumference, and subjective activity level at baseline.
Selected variables were signiﬁcant in correlation with weight
reduction (P<0.05). The psychological symptoms (GSI)
were included in the model as a control variable (r =− 0.19).
The chi-square test of the full model with all seven
predictors was signiﬁcant (n = 79, χ2 = 25.25, df = 7,4 Journal of Obesity
Table 3: Parameters and methods of assessment.
Parameter Method
Anthropometric:
Height, weight —> BMI Scale, chain, kg/m2
Waist circumference
Body composition BIA
Blood Serum:
Cholesterol/LDL-C Haemogram
Triglyceride
Nutrition:
Nutrition behaviour FEV
Food intake Recall (SOD)
Psychological Symptoms and Well-Being:
Depression/psychological symptoms SCL-90-R
Health related quality of life (HRQL) SF-36
Activity:
Fitlevel SOD
0.98
0.99
1
1.01
1.02
1.03
1.04
1.05
(week)
1 = t1 2345678 t2
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BMI < 40kg/m2
BMI > 40kg/m2
In-patient development of weight, standardized on −5% from
initial weight divided to BMI < 40kg/m2 (n = 35) and
BMI > 40kg/m2 (n = 64)
Figure 1:In-patientbodyweightofthesubgroupsBMI≶40kg/m2.
P = 0.001). Model-based classiﬁcations (cut-oﬀ of 0.5)
were correct in 55% of the cases for goal not attained and
in 94.9% of cases for goal attained. The overall rate of correct
classiﬁcations was 84.8%. Nagelkerkes R2, as the equivalent
for the proportion of the variance of the criterion explained
by the predictors, was 40.9%. The Hosmer-Lemeshow test
was not signiﬁcant (P = 0.763).
Duration of an in-patient therapy (P = 0.007) and the
BMI at baseline (P = 0.01) were signiﬁcant predictors to
attain the weight reduction goal, and a trend for the ﬁtlevel
at baseline (P = 0.089) was identiﬁed (Table 7). The odds
ratio of the duration of in-patient therapy and the ﬁtlevel
at baseline (OR < 1) demonstrated that a higher subjective
estimate of activity and also a longer hospital stay were
associated with a lower probability of achieving the weight
reduction goal.
Long-termoutcomes(1-yearfollowup)wereavailablefor
only 23 patients, 17 (73.9%) of which had a baseline BMI
>40kg/m2. Twelve (70.6%) of these 17 patients achieved and
maintained a weight reduction goal of 5–10% of their initial
weight. There was a little diﬀerence between participants
who make a regular use of the 3 monthly checks (n = 13)
including also a psychological interview beside the measures
of the objective and subjective parameters, to them, who
came irregular to the check (n = 10).
4. Discussion
The aim of the study was to demonstrate the achievement
of weight reduction in the subgroup BMI >40kg/m2 with
psychological comorbidities with a multimodal nondiet in-
p a t i e n tw e i g h tr e d u c t i o np r o g r a m .
The most interesting ﬁnding of the presented study was
a signiﬁcant weight loss over time (P<0.001) with a
group diﬀerence to BMI <40kg/m2 (P<0.05). While there
were signiﬁcant changes in most of the subjective and
objective parameters, there were only a few psychological
parameters in the subgroup BMI >40kg/m2 correlated with
weight reduction (somatoform dimension of the SCL-90 R;
r =− 0.316 and the subscale pain of SF-36; r = 0.441).
Findings of this study in this heterogenic ﬁeld of obese
patients with the psychological comorbidity are consistent
with past studies [22, 31, 32]. Psychological comorbidities
were associated with less weight loss as reported by Pagoto
et al. [22]. Whereas 16% of patients with major depression
achieved a weight reduction goal of ≥7%, 38% of the
nondepressed patients did it [22]. Comparable to Carroll et
al. [31] improvements in cholesterol, waist circumference,
and % body fat (P<0.05) as parameters of the metabolic
syndrome were demonstrated. Also there was no relevant
correlations between weight reduction and psychological
variables reported [31]. Equivalent to De Zwaan et al.,
analysis had identiﬁed no relationship between a higher BMI
and mental health [32]. So, patients with a BMI >40kg/m2
had no signiﬁcant group diﬀerence to a lower BMI in respect
of the general symptomatic index (F = 0.63; P = 0.803).
Also weight reduction was not related to PCS (r = 0.172)
and MCS (r = 0.094) of the SF-36.
T h er e l a t i v ew e i g h tr e d u c t i o nw a sh i g h e r( m e a nv a l u e
−6.9 ± 3.9%) than in the group BMI <40kg/m2 (mean value
−4.9 ± 2.4%) [33]. Goodpaster et al. [33] demonstrated
equivalent results of weight loss at patients with BMI
>40kg/m2 compared with lower BMI (10.9% versus 7% at
12 months). But, there was a high variability in both groups
at the presented study. While the goal of the 0.5kg each
week [28] was achieved by 52 participants (81.3%), 42 of
the 64 (65.6%) participants in this group obtained also the
successful weight loss, deﬁned as ≥5% from initial weight at
1-year followup [5, 13]. This value is evident for reducing
the risk of cardiovascular diseases [34–36]. As already above-
mentioned parameters of the metabolic syndrome that
decreased signiﬁcantly (P<0.05), there were also positive
eﬀects without weight reduction [35]. Body composition is
one of the most interesting parameters demonstrating the
improvement of risk proﬁle. Improvements could be shownJournal of Obesity 5
Table 4: Descriptive statistic of patients with BMI ≶40 kg/m2.
N Mean value S.E. N Mean value S.E. N Mean value S.E.
BMI > 40kg/m2 BMI < 40 kg/m2
Age (years) 99 43,79 12,44 64 43,76 12,45 35 43,83 12,61
Weight (kg) 99 129,60 35,49 64 143,29 35,69 35 104,56 16,54
BMI (kg/m2) 99 44,96 9,93 64 49,99 8,75 35 35,76 2,75
Waist circumference (cm) 98 136,53 22,75 63 147,18 20,36 35 117,37 11,52
Body fat (%) 98 44,72 7,28 63 47,01 7,01 35 40,61 5,86
GSI 97 ,9432 ,62 64 ,95 ,65 33 ,9212 ,56
Fitlevel 80 24,74 15,67 54 21,83 15,58 26 30,77 14,35
Weight reduction in % 93 −6,01 3,38 59 −6,63 3,69 34 −4,95 2,47
Duration in-patient therapy (days) 99 71,39 16,20 64 75,33 14,9 35 64,20 16,21
Table 5: Descriptive statistics of the subgroup BMI >40kg/m2.
Descriptive statistic n = 64 t1 t2
N min max Mean value S.E. N min max Mean value S.E.
Psychological parameters
BDI 58 0 38 19,01 9,55 52 0 34 9,97∗∗ 7,56
SCL90R somatoform dimension 64 1 36 12,20 9,33 61 0 35 8,28∗∗ 8,56
SCL90R depressive dimension 64 0 47 16,12 11,48 61 0 41 8,7∗∗ 8,76
SCL90R general symptomatic index (GSI) 64 0,02 3,39 0,95 0,65 61 0 2,89 0,58∗∗ 0,52
IIPD 64 0,41 2,8 1,71 0,47 61 0,09 2,64 1,40∗∗ 0,55
TAS26 37 25 63 46,09 9,99 35 30 69 45,97 10,03
Eating habits
FEV cognitive restraint 33 1 15 7,18 3,74 31 1 20 12,16∗∗ 5,33
FEV uncontrolled eating 33 1 16 10,24 3,75 31 1 15 6,55∗∗ 3,86
Fitlevel 54 0 58 21,83 15,58 50 8 99 65,28∗∗ 16,63
Health related quality of life
SF36 physical functioning 37 5 95 46,38 23,98 35 0 100 62,86∗∗ 26,13
SF36 physical role limitation 37 0 100 29,28 36,57 35 0 100 56,91∗∗ 43,04
SF36 pain 37 0 100 48,34 28,12 35 12 100 62,59∗∗ 27,48
SF36 general health 37 19 92 50,28 17,11 35 25 97 63,69∗∗ 19,09
SF36 vitality 37 5 80 34,32 17,13 35 15 100 58,29∗∗ 19,81
SF36 social functioning 37 0 100 54,05 27,01 35 12,5 100 68,93∗∗ 27,35
SF36 emotional role limitation 37 0 100 39,64 39,16 35 0 100 66,67∗∗ 45,01
SF36 mental health 37 12 100 55,24 19,09 35 24 100 66,86∗∗ 19,00
SF36 physical summary score (PCS) 37 15 52 35,72 10,00 35 15,2 56,3 42,51∗∗ 10,56
SF36 mental summary score (MCS) 37 20 61,7 39,68 11,53 35 22,8 63,1 47,51∗∗ 11,60
Anthropometric parameters
Weight (kg) 64 104,6 322,5 143,29 35,68 64 96 299 133,13∗∗ 32,01
BMI 64 38 84 49,99 8,74 61 35,1 77,8 46,43∗∗ 8,01
Waist circumference (cm) 63 115 230 147,18 20,36 64 112 220 139,8∗∗ 19,47
% Body fat 63 28,7 60 47,01 7,01 58 23,2 58,1 44,39∗∗ 7,59
Blood parameters
Cholesterol (mg/dL) 58 126 305 189,71 38,72 57 118 267 179,84∗ 34,81
LDL-cholesterol (mg/dL) 54 48 201 110,41 33,54 56 40 182 106,36 32,35
Triglycerides (mg/dL) 58 75 466 166,12 76,62 57 65 329 159,6 57,32
t1: pre treatment, t2: posttreatment.
∗Correlation is signiﬁcant at P<0,05 (two-tailed).
∗∗Correlation is signiﬁcant at P<0,01 (two-tailed).6 Journal of Obesity
Table 6: Spearman correlation matrix of weight reduction and selected variables at BMI >40kg/m2.
Spearman-Rho
Duration of
in-patient
therapy
General
Symptomatic
Index (GSI)
Somatoform
dimension
SCL-90 R
Depressive
dimension
SCL-90R
Physical
summary
score SF36
(PCS)
Mental
summary
score SF 36
(MCS)
Age Waist % body
fat
Fit-
level
Weight
reduction
r −,153 ,144 ,316∗ ,170 ,172 ,094 −,083 ,612∗∗ ,855∗∗ ,160
N 64 61 61 61 35 35 64 63 58 50
∗∗Correlation is signiﬁcant at P<0,01 (two-tailed).
∗Correlation is signiﬁcant at P<0,05 (two-tailed).
Table 7: Variables in the logistic regression model.
B Wald Sig. OR
95% C.I. for OR
Lower Upper
Step 1a
Sex (1) ,84 1,06 ,304 2,309 ,47 11,38
MTS (1) ,03 ,00 ,975 1,026 ,21 5,09
Age ,00 ,01 ,944 1,002 ,94 1,07
Duration in-patient therapy −,08 7,35 ,007 ,925 ,87 ,98
BMI ,13 6,64 ,010 1,143 1,03 1,27
Fitlevel −,04 2,89 ,089 ,963 ,92 1,01
GSI ,24 ,16 ,686 1,277 ,39 4,18
Constant 1,68 ,33 ,564 5,386
aVariables entered on step 1: sex, metabolic syndrome (MTS), age, duration of in-patient therapy, BMI, ﬁtlevel and general symptomatic index (GSI) at
baseline.
independent of weight reduction [9]. Waist circumference is
more closely correlated with visceral obesity than the total
body fat mass [36], but analysis demonstrated signiﬁcant
changes in both, waist circumference and body fat (P =
0.001). Similar to our ﬁndings, Galani and Schneider
reported a signiﬁcant decrease of body weight (P<0.0001),
total cholesterol (P = 0.027), and waist circumference after
lifestyle interventions [36]. So, the focus must be also on
evaluation of body composition and blood markers for the
metabolic syndrome to identify the beneﬁts of a lifestyle
intervention.
We found that a higher duration of in-patient therapy
is not signiﬁcantly correlated with weight reduction (r =
0.153). This ﬁnding was diﬀerent to the study of Beutel et
al. [37]. In their equivalent study, a signiﬁcant correlation of
weight loss with a longer in-patient treatment (r = 0.4) was
demonstrated[37].Inourresearch,theincludedparticipants
demonstrated that the 5% weight reduction goal could be
achieved at week eight.
These ﬁndings were also deﬁned at the binary logistic
regression analysis. The odds ratio of the in-patient stay
was 0.925 and consequentially the odds to achieve the
weight reduction goal decrease with a longer in-patient
therapy. Longer stays in hospital were reported to correlate
with a higher load of psychological comorbidity. So, it
could be expected that participants with a higher load of
psychological symptoms need a longer in-patient therapy.
Also interesting was the subjective estimation of the activity.
Findings presented an odds ratio of 0,963 and therefore an
estimation of a higher subjective ﬁtlevel decreases the odds
ofobtainingtheweightreductiongoal.Thesedataimplicated
that the self-estimation often diﬀers from the reality.
The dependent variable of weight reduction of the binary
logistic regression model was the reference value of 0.5kg
each week [28]. This goal of 0.5kg weight reduction was
moreeasilyachievedforhigherobese individuals. Atpresent,
there exists only a relative weight reduction reference value
for long-term maintenance. So, it will be more important
to ﬁnd cutoﬀ points of relative weight reduction for an in-
patient therapy.
Further investigation is necessary to understand and to
identify the factors which will demonstrate the eﬀectiveness
of a successful long-term weight loss of a nondiet program
for participants with a BMI > 40kg/m2. Information of the
drop-outswhytheydonotvisittheout-patientfollowupcare
should be included.
Future studies should have a control group for com-
parison of the progression of the increasing problem of
obesity. Standardized measures and also the inclusion of
objective parameters, particularly of activities to check the
self-estimation of ﬁtness against reality, would be involved.
Findings of this study demonstrated that the primary
outcome should not be only the weight reduction but rather
the beneﬁts of lifestyle modiﬁcation [9] and their increasing
quality of life. Also the emotional regulation of food intake,
because this is often the problem for long-term behaviour
modiﬁcation, must be included.
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